An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
Martin K ChurchGiorgio Walter CanonicaPiotr KunaMarcus MaurerRalph MosgesZ NovakNikolaos G PapadopoulosPablo Rodríguez Del Ríonull nullPublished in: Expert review of clinical immunology (2023)
the high degree of agreement obtained suggests a wide awareness of the burden of allergic rhinoconjunctivitis and chronic urticaria among experts from all over the world and reflect a broad consensus on the role of second generation antihistamines in general and of bilastine in particular for their management.